Hainan Shuangcheng Pharmaceuticals Co., Ltd.
002693.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.76B
Close$
$-2.16
124.3% downside
Current Fair Value
124.3% downsideOvervalued by 124.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.76 Billion |
|---|---|
| Enterprise Value | $3.98 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.05 |
| Beta | 0.48 |
| Outstanding Shares | 414,689,750 |
Return
| Return on Equity | 12.00% |
|---|---|
| Return on Assets | 6.31% |
| Return on Invested Capital | 9.81% |
Valuation & Multiples
| P/E Ratio | 73.03 |
|---|---|
| PEG | -33.07 |
| Price to Sales | - |
| Price to Book Ratio | 8.89 |
| Enterprise Value to Revenue | 12.85 |
| Enterprise Value to EBIT | 81.57 |
| Enterprise Value to Net Income | 77 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hainan Shuangcheng Pharmaceuticals Co., Ltd.
474 employees
CEO: Jianming Li Hainan Shuangcheng Pharmaceuticals Co., Ltd. operates internationally, undertaking the entire lifecycle of synthetic peptide drugs and active pharmaceutical ingredients (APIs), from initial research and development through manufacturing ...